SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-17-116495
Filing Date
2017-04-07
Accepted
2017-04-07 17:22:35
Documents
62
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d368363d10qa.htm 10-Q/A 753132
2 EX-31.1 d368363dex311.htm EX-31.1 7137
3 EX-31.2 d368363dex312.htm EX-31.2 7048
4 EX-32 d368363dex32.htm EX-32 5656
  Complete submission text file 0001193125-17-116495.txt   5094343

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT insy-20160630.xml EX-101.INS 1292411
6 XBRL TAXONOMY EXTENSION SCHEMA insy-20160630.xsd EX-101.SCH 38131
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20160630_cal.xml EX-101.CAL 59264
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20160630_def.xml EX-101.DEF 276086
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20160630_lab.xml EX-101.LAB 323300
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20160630_pre.xml EX-101.PRE 327352
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35902 | Film No.: 17750825
SIC: 2834 Pharmaceutical Preparations